Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1885-1893

  Koyama, Sekiya ^a   Sato, Etsuro ^a   Nomura, Hiroshi ^a   Kubo, Keishi ^a   Miura, Masakazu ^b   Yamashita, Tetsuji ^b   Nagai, Sonoko ^c   Izumi, Takateru ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CYCLOHEXIMIDE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS CELL TYPE 2; MOLECULAR WEIGHT; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PNEUMONIA; PRIORITY JOURNAL;

EID: 0031740441     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65702-1     Document Type: Article

References (45)

1. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE: Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiological significance. Am Rev Respir Dis 1986, 133:218-225
2. Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, Bitterman PB, Crystal RG: Pathogenesis of the granulomatous lung disease. Am Rev Respir Dis 1984, 130:476-496
3. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG: Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981, 68:S259-S269
4. Blusse van Oud Alblas A, van der Linden-Schrever B, van Furth R: Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG. Am Rev Respir Dis 1983, 128:276-281
5. Adanson IYR, Bowden JH: Role of monocytes and interstitial cell cells in the generation of alveolar macrophages. II. Kinetic studies after carbon loading. Lab Invest 1980, 42:518-531
6. Shellito J, Esparza C, Armstrong C: Maintenance of the normal alveolar macrophage cell population. Am Rev Respir Dis 1987, 135: 78-82
7. Blusse van Oud Alblas A, Mattie H, van Furth R: A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet 1983, 16:211-219
8. Bitterman PB, Saltzman LE, Adelberg S, Ferrans VJ, Crystal RG: Alveolar macrophage replication: one mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 1984, 74:460-469
9. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141: 471-501
10. Nathan CF: Secretory products of macrophages. J Clin Invest 1987, 79:319-326
11. Merill WW, Naegel GP, Matthay RA, Reynolds HY: Alveolar macrophage-derived chemotactic factor for neutrophils: kinetics of in vitro production and partial characterization. J Clin Invest 1980, 65:268-276
12. Hunninghake GW, Gadek JE, Fales HM, Crystal GR: Human alveolar macrophage-derived chemotactic factor for neutrophils: stimuli and partial characterization. J Clin Invest 1980, 66:473-483
13. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989, 243: 1467-1469
14. Strieter RM, Showel HJ, Remnick DG, Lynch JP III, Genord M, Raiford C, Eskandari M, Marjs RM, Kunkel SL: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989, 264:10621-10626
15. Standiford TJ, Kunkel SL, Basha MB, Chensue SW, Lynch JP III, Toews GB, Westwick J, Strieter RM: lnterleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung J Clin Invest 1990, 86:1945-1953
16. Nakamura H, Yoshimura K, Jahhe HA, Crystal RG: Interleukin-8 expression in human bronchial epithelial cells. J Biol Chem 1991, 266: 19611-19617
17. Koyama S, Rennard Sl, Leikauf GD, Shoji S, Von Essen S, Claasen L, Robbins RA: Endotoxin stimulates bronchial epithelial cells to release chemotactic factor for neutrophils. J Immunol 1991, 147:4293-4301
18. Mason J, Williams MC: Type II alveolar cell: defender of the alveolus. Am Rev Respir Dis 1977, 116:81-91
19. Koyama S, Sato E, Nomura H, Kubo K, Nagai S, Izumi T: Type II pneumocytes release chemoattractant activity for monocytes constitutively. Am J Physiol 1997, 272:L830-L837
20. Rosental GJ, Germolec DR, Blazka ME, Corsini E, Simeonova P, Pollock P, Kong LY, Kwon J, Luster MI: Asbestos stimulates IL-8 production from human lung epithelial cells. J Immunol 1994, 153: 3237-3244
21. Crestani B, Cornilett P, Dehoux M, Rolland C, Guenounou M, Aubier M: Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo: regulation by alveolar macrophage secretory products. J Clin Invest 1994, 94:731-740
22. Hahon N, Castranova V: Interferon production in rat type II pneumocytes and alveolar macrophages. Exp Lung Res 1989, 15:429-445
23. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM: Alveolar macrophage-derived cytokines induces monocyte chemoattractant protein-I expression from human pulmonary type II-like epithelial cells. J Biol Chem 1991, 266:9912-9918
24. Proud D, Kaplan AP: Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988, 6:49-83
25. Turino GM, Rodrigues JR, Greenbaum LM, Mandel I: Mechanisms of pulmonary injury. Am J Med 1974, 57:493-505
26. Sato E, Koyama S, Nomura H, Kubo K, Sekiguchi M: Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. J Immunol 1996, 157:3122-3129
27. Koyama S, Rennard SI, Robbins RA: Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1995, L38-L44
28. Riding PC, Blocher CR, Fisher BJ, Fowler AA III, Sugerman HJ: Beneficial effects of a bradykinin antagonist in a model of gramnegative sepsis. J Trauma 1995, 39:81-89
29. Leiber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor cell line from human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976, 17:62-70
30. Ando T, Shimamoto K, Nakahashi Y, Nishitani T, Hosoda S, Ishida H, Tanaka S, Iimura O: Recent Progress on Kinins. Edited by Fritz H, Dietze G, Fiedler F, Haberland GL: Kinins. Boston, Birkhauser Verlag, 1982, pp 222-232
31. Böyum A: Isolation of mononuclear cells from human blood. Scand J Invest 1968, 21:77-98
32. Harrath L, Falk W, Leonard EJ: Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multi well assembly. J Immunol Methods 1980, 37:39-45
33. Zigmond SH, Hirsch GJ: Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of cell-derived chemotactic factor. J Exp Med 1973, 137:387-410
34. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ: Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987, 135:176-180
35. Mak JCW, Barnes PJ: Autoradiographic visualization of bradykinin receptors in human and guinea pig lung. Eur J Pharmacol 1991, 194:37-44
36. Farmer SG, Burch RM, Meeker SN, Willikins DE: Evidence for a pulmonary bradykinin B3 receptor. Mol Pharmacol 1989, 36:1-7
37. Farmer SG, Willikins DE, Meeker SA, Seeds EA, Page CP: Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia guinea-pigs. Br J Pharmacol 1992, 107:65-72
38. Krueger J, Ray A, Sehgal PB: Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 1991, 45:327-334
39. Ulich TR, Yin S, Guo K, Yi ES, Rermick D, Del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor-β inhibit acute inflammation. Am J Pathol 1991, 138: 1097-1101
40. Jones KP, Reynolds SP, Capper SJ, Kalinka S, Edwards JH, Davis BH: Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects. Clin Exp Immunol 1991, 83:30-34
41. Grigg JM, Barber A: Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture on membrane. Am Rev Respir Dis 1992, 145:782-786
42. Soliman DM, Twigg HII: Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 1992, 236:L471-L478
43. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB: Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987, 84:5788-5792
44. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB: Distribution and modulation of the cellular receptor for transforming growth factor-beta J Cell Biol 1987, 105:965-975
45. Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A: Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1988, 72:1456-1480